N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes

Oxygen-insensitive enzymatic reduction of oximes to imines

Heberling, S., Girreser, U., Wolf, S., & Clement, B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.037 · Cited by 18

Are drug metabolites able to cause T-cell-mediated hypersensitivity reactions?

Sullivan, A. K., Gibson, A., Park, B. K., & Naisbitt, D. J. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.992780 · Cited by 19

A proposed mechanism for the adverse effects of acebutolol: CES2 and CYP2C19-mediated metabolism and antinuclear antibody production

Muta, K., Fukami, T., & Nakajima, M. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.09.016 · Cited by 17

Pharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of Tuberculosis

Alsaad, N., Dijkstra, J. A., Akkerman, O. W., de Lange, W. C. M., van Soolingen, D., Kosterink, J. G. W., van der Werf, T. S., & Alffenaar, J. C. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02175-15 · Cited by 17

CYP2C19 genotypes in a population of healthy volunteers and in children with hematological malignancies in Gaza Strip.

Sameer, A.-E. I., Amany, G. M., Abdela, A. A., & Fadel, S. A. (2009) · PubMed · Cited by 14

Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes

Clement, B., Behrens, D., Amschler, J., Matschke, K., Wolf, S., & Havemeyer, A. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.12.028 · Cited by 14

Inhibition of cytokine production and interference in IL‐2 receptor‐mediated Jak‐Stat signaling by the hydroxylamine metabolite of sulfamethoxazole

Hess, D. A., O'Leary, E. F., Lee, J. T., Almawi, W. Y., Madrenas, J., & Rieder, M. J. (2001) · The FASEB Journal · doi:10.1096/fj.00-0583fje · Cited by 14

Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats

Konishi, H., Yoshimoto, T., Morita, K., Minouchi, T., Sato, T., & Yamaji, A. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702298 · Cited by 14

Identification of rat cytochrome P450 forms involved in the metabolism of clausenamide enantiomers

Zhu, C. J., & Zhang, J. T. (2003) · Chirality · doi:10.1002/chir.10228 · Cited by 14

Drug interaction of (S)-warfarin, and not (R)-warfarin, with itraconazole in a hematopoietic stem cell transplant recipient

Miura, M., Takahashi, N., Kanno, S., Kato, S., Nara, M., Itoh, M., Saitoh, H., Yoshioka, T., Kameoka, Y., Fujishima, N., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.06.035 · Cited by 13

Increased risk of occupational trichloroethylene hypersensitivity syndrome at exposure levels higher than 15 mg/L of urinary trichloroacetic acid, regardless of whether the patients had the HLA-B*13:01 allele

Wang, H., Nakajima, T., Ito, Y., Naito, H., Zhao, N., Li, H., Qiu, X., Xia, L., Chen, J., Wu, Q., et al. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109972 · Cited by 13

Spatial-temporal profiling of antibiotic metabolites using graphite dots-assisted laser desorption ionization mass spectrometry

Lv, R., Shi, R., Wu, E., Ma, C., Guo, R., Li, J., Ouyang, F., Fang, Q., Hu, L., Sun, C., et al. (2020) · Talanta · doi:10.1016/j.talanta.2020.121371 · Cited by 11

Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study

Lavergne, S. N., Volkman, E. M., Maki, J. E., Yoder, A. R., & Trepanier, L. A. (2004) · Toxicology · doi:10.1016/j.tox.2004.11.009 · Cited by 12

A Novel Class of N‐Sulfonyl and N‐Sulfamoyl Noscapine Derivatives that Promote Mitotic Arrest in Cancer Cells

Yong, C., Devine, S. M., Gao, X., Yan, A., Callaghan, R., Capuano, B., & Scammells, P. J. (2019) · ChemMedChem · doi:10.1002/cmdc.201900477 · Cited by 12

Evaluation of Polymorphisms in the Sulfonamide Detoxification Genes CYB5A and CYB5R3 in Dogs with Sulfonamide Hypersensitivity

Funk‐Keenan, J., Sacco, J., Wong, Y. Y., Rasmussen, S., Motsinger‐Reif, A. A., & Trepanier, L. A. (2012) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2012.00965.x · Cited by 12

ROLE OF HUMAN CYCLOOXYGENASE-2 IN THE BIOACTIVATION OF DAPSONE AND SULFAMETHOXAZOLE

Vyas, P. M., Roychowdhury, S., & Svensson, C. K. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006890 · Cited by 12

RNA expression profiling in sulfamethoxazole‐treated patients with a range of in vitro lymphocyte cytotoxicity phenotypes

Reinhart, J. M., Rose, W. E., Panyard, D. J., Newton, M. A., Liebenstein, T., Yee, J. S., & Trepanier, L. A. (2018) · Pharmacology Research & Perspectives · doi:10.1002/prp2.388 · Cited by 11

The role of biotransformation and oxidative stress in 3,5-dichloroaniline (3,5-DCA) induced nephrotoxicity in isolated renal cortical cells from male Fischer 344 rats

Racine, C. R., Ferguson, T., Preston, D. L., Ward, D. B., Ball, J. G., Anestis, D. K., Valentovic, M. A., & Rankin, G. O. (2016) · Toxicology · doi:10.1016/j.tox.2016.01.006 · Cited by 11

Pharmacogenetics and blood dyscrasias

Spielberg, S. P. (1996) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1996.tb01653.x · Cited by 11

Herb‐Drug Interaction: Effects of Relinqing® Granule on the Pharmacokinetics of Ciprofloxacin, Sulfamethoxazole, and Trimethoprim in Rats

Lü, Y., Gong, Z., Xie, Y., Pan, J., Sun, J., Li, Y., Chen, S., Li, Y., Wang, Y., & Huang, Y. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/6194206 · Cited by 10

HIV-1 tat expression and sulphamethoxazole hydroxylamine mediated oxidative stress alter the disulfide proteome in Jurkat T cells

Adeyanju, K., Bend, J. R., Rieder, M. J., & Dekaban, G. A. (2018) · Virology Journal · doi:10.1186/s12985-018-0991-x · Cited by 10

A Comparison of the Effect of Five Phenothiazines on Hepatic CYP Isoenzymes in Rats

Tateishi, T., Kumai, T., Watanabe, M., Tanaka, M., & Kobayashi, S. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb02018.x · Cited by 10

The Hydroxylamine of Sulfamethoxazole Synergizes with FK506 and Cyclosporin A, Inhibiting T-Cell Proliferation

Hess, D. A., Bird, I. A., Almawi, W. Y., & Rieder, M. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36616-9 · Cited by 10

Oral Treatment with Trimethoprim-Sulfamethoxazole and Zidovudine Suppresses Murine Accessory Cell-Dependent Immune Responses

Freund, Y. R. (2000) · Toxicological Sciences · doi:10.1093/toxsci/55.2.335 · Cited by 10

Cytochrome P450 isoform-specific in vitro methods to predict drug metabolism and interactions

Taavitsainen, P. (2001) · Cited by 9

Extrahepatic Targets and Cellular Reactivity of Drug Metabolites

Orhan, H. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140826113716 · Cited by 10

N-Dealkylation of Chlorimipramine and Chlorpromazine by Rat Liver Microsomal Cytochrome P450 Isoenzymes

Valoti, M., Frosini, M., Palmi, M., Matteis, F. D., & Sgaragli, G. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb06915.x · Cited by 9

Nonenzymatic formation of a novel hydroxylated sulfamethoxazole derivative in human liver microsomes: implications for bioanalysis of sulfamethoxazole metabolites

Sanderson, J. P., Hollis, F. J., Maggs, J. L., Clarke, S. E., Naisbitt, D. J., & Park, B. K. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021246 · Cited by 8

Advancing the enzymatic removal of antibiotics with unspecific peroxygenase and vanadium chloroperoxidase

de Boer, S. R., Sastre, D., Castillo, A., Méndez, S. B., Hollmann, F., Lores, M., Schäffer, A., & Moreira, M. T. (2025) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2025.115795 · Cited by 8

Trimethoprim/Sulfamethoxazole Does Not Affect the Steady‐State Disposition of Indinavir

Sturgill, M. G., Seibold, J. R., Boruchoff, S. E., Yeh, K. C., Haddix, H., & Deutsch, P. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922011737 · Cited by 8

Comment: sulfonamide cross-reactivity: fact or fiction?

Phillips, E. J., & Knowles, S. R. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e350a · Cited by 8

The Effect of Cimetidine on the Formation of Sulfamethoxazole Hydroxylamine in Patients with Human Immunodeficiency Virus

Lehmann, D. F., Newman, N. B., & Morse, P. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04454.x · Cited by 7

The truth about the lower plasma concentration of the (−)-isomer after racemic doxazosin administration in rats: Stereoselective inhibition of the (−)-isomer by the (+)-isomer at CYP3A

Kong, D., Li, Q., Zhang, P., Zhang, W., Yaqin, Z., & Ren, L. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.06.022 · Cited by 6

Drug hypersensitivity reactions in patients with HIV disease

Pirmohamed, M., Drummond, N. S., Naisbitt, D. J., & Park, B. K. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.3.395 · Cited by 6

Towards the development of mechanism-based biomarkers to diagnose drug hypersensitivity

Durán‐Figueroa, N., Badillo-Corona, J. A., Naisbitt, D. J., & Castrejón-Flores, J. L. (2015) · Toxicology Research · doi:10.1039/c4tx00238e · Cited by 6

The Long Evans Cinnamon (LEC) rat develops hepatocellular damage in the absence of antimicrosomal antibodies

Bedard, K., Fuentealba, I. C., & Cribb, A. E. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00169-4 · Cited by 6

Identification of rat and human cytochrome P450 forms involved in the metabolism of the thromboxane A2 receptor antagonist (+)-S-145.

Yamaguchi, Y., Kirita, S., Baba, T., Aoyama, J., Touchi, A., Tukey, R. H., Guengerich, F. P., & Matsubara, T. (1997) · PubMed · Cited by 6

T Cell Responses to Drugs and Drug Metabolites

Earnshaw, C. J., Pecaric-Petkovic, T., Park, B. K., & Naisbitt, D. J. (2013) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-0726-5_10 · Cited by 6

The effect of repeat administration of GTS-21 on mixed-function oxidase activities in rat

Azuma, R., Komuro, M., Black, S. R., & Mathews, J. M. (1999) · Toxicology Letters · doi:10.1016/s0378-4274(99)00150-2 · Cited by 5

Suboptimal cotrimoxazole prophylactic concentrations in HIV‐infected children according to the WHO guidelines

Pressiat, C., Mea-Assande, V., Yonaba, C., Tréluyer, J., Dahourou, D. L., Amorissani‐Folquet, M., Blanche, S., Eboua, F. T., Ye, D., Lui, G., et al. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13397 · Cited by 6

Comparisons of Oxidative Metabolism and Reductive Capacity in Sulfonamide‐Tolerant and ‐Intolerant Patients with Human Immunodeficiency Virus

Lehmann, D. F., Holohan, P. D., & Blair, D. C. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04169.x · Cited by 5

Effect of lipopolysaccharide (LPS)-evoked host defense activation on hepatic microsomal formation and reduction of sulfamethoxazole hydroxylamine in the rat12Abbreviations: ADR, adverse drug reaction; CYP, cytochrome P450; LPS, lipopolysaccharide; NMHR, NADH-dependent microsomal hydroxylamine reductase; SMX, sulfamethoxazole; SMX-HA, sulfamethoxazole hydroxylamine; and SMX-TMP, sulfamethoxazole-trimethoprim.

Cribb, A. E., McQuaid, T., & Renton, K. W. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00691-8 · Cited by 5

Bullous allergic drug eruption with presence of myeloperoxidase and reorganization of the dermal vessels observed by using CD34 and collagen IV antibodies

Vélez, A. M. A., Klein, D., Smoller, B. R., MD., M., & Howard, M. S. (2011) · North American Journal of Medical Sciences · doi:10.4297/najms.2011.382 · Cited by 4

Interactions between HIV infection and malaria in children living in sub-Saharan Africa in the era of widening access to improved interventions

Gasasira, A. F. (2010) · eScholarship (California Digital Library) · Cited by 4

Potential Complementary Therapy for Adverse Drug Reactions to Sulfonamides: Chemoprotection Against Oxidative and Nitrosative Stress by TCM Constituents and Defined Mixtures

Zhang, L., Chen, D., Xia, X. Y. X. Y., Yip, C., Rieder, M. J., & Bend, J. R. (2015) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3sp5w · Cited by 3

Hypersensitivity adverse drug reactions in children: Pathophysiology and therapeutic implications

Rieder, M. J. (2001) · Current Therapeutic Research · doi:10.1016/s0011-393x(01)80095-3 · Cited by 3

Comparative pharmacokinetics of trimethoprim–sulfadiazine and trimethoprim–sulfamethoxazole in dogs

Ekstrand, C., Löwgren, M., Erkas, M., Devreese, M., Baere, S. D., Vo-Thanh, J., & Ferran, A. A. (2026) · BMC Veterinary Research · doi:10.1186/s12917-026-05604-7 · Cited by 2

Pathophysiologic Mechanisms of Immune-mediated Drug Hypersensitivity Reactions to Sulfonamides

Sultan, E. A. (2015) · Scholarship@Western (Western University) · Cited by 2

Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk

Wong, Y. Y., Johnson, B. P., Friedrich, T. C., & Trepanier, L. A. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.312 · Cited by 2

CYP2C9, CYP2D6, G6PD, GCLC, GSTM1 and NAT2 gene polymorphisms and risk of adverse reactions to sulfamethoxazole and ciprofloxacin in San Luis Potosí, Mexico

Hernández-Verdín, I., Ganelón-Ríos, A., Pettet-Ruiz, G., Sánchez-Garza, M., Reinoso-Reyes, J., & López‐Revilla, R. (2019) · Meta Gene · doi:10.1016/j.mgene.2019.100574 · Cited by 2

Sulfonamide-induced cutaneous drug reactions

Vyas, P. M. (2006) · doi:10.17077/etd.rttumisz · Cited by 2

N-Acetyltransferase (NAT) 1 and NAT2 Enzyme Activities Drive Interindividual Variability in Sulfamethoxazole N-Acetylation

Lanphier, R. M., Latham, B. D., Gerringer, A. J., Interrante, T., Jones, C. D., De Buysscher, T., Fallon, J. K., & Jackson, K. D. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100195 · Cited by 1

Study on herb-drug interactions

Yang, L. L. (2011) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27333027 · Cited by 1

Allergic Reactions to Drugs

Grillo, M. P. (2008) · doi:10.1002/9780470439265.ch22 · Cited by 1

Allergic Reactions to Drugs

Grillo, M. P. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse121 · Cited by 1

Allergic Reactions to Drugs

Grillo, M. P. (2022) · doi:10.1002/9781119851042.ch20 · Cited by 1

In vitro approaches in evaluation and prediction of drug-drug interactions involving the inhibition of cytochrome P450 enzymes

Xia, W. (2002) · Työväentutkimus Vuosikirja

Reactive iminoquinone metabolites of indomethacin and carbamazepine, implications for drug-induced idiosyncratic reactions

Ju, C. H. (1999) · Library and Archives Canada (Government of Canada)

Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR Tuberculosis

Dijkstra, J. A. (2017) · University of Groningen research database (University of Groningen / Centre for Information Technology)

Metabolisms of Foreign Compounds

Chen, C. (2020) · Springer eBooks · doi:10.1007/978-3-030-41679-9_4

ATTENUATION OF OXIDATIVE AND NITROSATIVE STRESS BY PURE CONSTITUENTS OF TRADITIONAL CHINESE REMEDIES

Zhang, L. (2011) · Scholarship@Western (Western University)

ORAL COMMUNICATIONS

(1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16425.x

Pathomechanisms of Drug Hypersensitivity Targeting the Liver and Skin

Thomson, P., Naisbitt, D. J., & Ogese, M. O. (2022) · Springer eBooks · doi:10.1007/978-3-030-82743-4_6

Genetic Diversity of Cytochrome P450 2C9 (CYP2C9) in HIV/AIDS Positive Patients Regarding Side Effects Induced by Cotrimoxazole at the ALNADJMA Multipurpose Center in N'Djamena, Chad

François, M. O., Tah, C. F., Oscar, A. F., Abakar, M. N. A., Joseph, L., Otchom, B. B., & Mbacham, W. F. (2025) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v15i5.7154

Population pharmacokinetic modeling and Monte Carlo simulation–based dosing optimization of trimethoprim–sulfamethoxazole in critically ill patients

Wang, M., Li, C., Fu, X., Wang, F., Zhou, X., Zhang, B., Xu, W., Liang, L., Lei, Z., Qu, H., et al. (2026) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-026-04019-5

Études pharmacocinétiques d'antirétroviraux et du cotrimoxazole chez les enfants de 6 mois à 3 ans, par approche de population

Pressiat, C. (2017) · theses.fr (ABES) · doi:10.70675/b34c9ceaz1d0cz4ac9za0dfz8a0f47cfd7e2

Vasculitis Cutánea Leucocitoclástica secundaria al uso de trimetoprim-sulfametoxazol en un adolescente: a propósito de un caso

Arenas, D. C. V., Mantilla, S. S., Rodríguez, A. P., & Ávila, L. M. S. (2025) · Revista Ciencias Biomédicas · doi:10.32997/rcb-2025-5949

Cross-Species Multitask Learning with Molecular and ADME Descriptors for Liver Microsomal Metabolic Stability

Seomun, S., & Yoo, S. (2026) · Computational and Structural Biotechnology Journal · doi:10.34133/csbj.0184

Model-Based Evaluation of the Warfarin–Sulfamethoxazole Drug–Drug Interaction

Takeda, K., Hirai, T., Okamoto, K., Sugioka, A., Okada, A., & Shibata, N. (2026) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-026-01041-x

Short Communication Nonenzymatic Formation of a Novel Hydroxylated Sulfamethoxazole Derivative in Human Liver Microsomes:

Bioanalysis, I., & Metabolites, S. (2008)

Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine

Cribb, A. E., & Spielberg, S. P. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08652-0 · Cited by 65

The effect of genetic polymorphisms in CYP2C9 on sulphamethoxazole N-hydroxylation

Gill, H. J., Tjia, J. F., Kitteringham, N. R., Pirmohamed, M., Back, D. J., & Park, B. K. (1999) · Pharmacogenetics · doi:10.1097/00008571-199902000-00007 · Cited by 48

Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes

Clement, B., Behrens, D., Amschler, J., Matschke, K., Wolf, S., & Havemeyer, A. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.12.028 · Cited by 14

Nonenzymatic formation of a novel hydroxylated sulfamethoxazole derivative in human liver microsomes: implications for bioanalysis of sulfamethoxazole metabolites

Sanderson, J. P., Hollis, F. J., Maggs, J. L., Clarke, S. E., Naisbitt, D. J., & Park, B. K. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021246 · Cited by 8